75. DMT for Depression with Dr Graham Campbell

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week’s episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.

Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.

Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don’t miss out – listen to our latest episode now!

Listen to Graham’s music here!

Psychedelic Assisted Therapy

Small Pharma



Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant


Bipolar disorder

Schizoaffective disorder

Trial of Psilocybin versus Escitalopram for Depression

Rosalind Watts

Michelle Baker Jones

Roberta Murphy 

Jonny Martell

Ashleigh Murphy-Beiner


Institute of Psychedelic Therapy

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy

Sussex Partnership NHS Foundation Trust


Monoamine oxidase inhibitor


The ACE Model

The hidden therapist: evidence for a central role of music in psychedelic therapy

Max Cooper

Music and the Mind by Anthony Storr

Mind Foundation

Maria Papaspyrou